TreeWAS – Variant ID: rs1055254

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E04.9 Non-toxic goitre, unspecified	1.000	0.000	0.000
E04.2 Non-toxic multinodular goitre	1.000	0.000	0.000
E04 Other non-toxic goitre	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	0.955	0.045	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.919	0.081	0.000
E07 Other disorders of thyroid	0.896	0.104	0.000
E04.0 Non-toxic diffuse goitre	0.881	0.119	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.865	0.135	0.000
E06 Thyroiditis	0.850	0.150	0.000
E07.9 Disorder of thyroid, unspecified	0.833	0.167	0.000
E04.1 Non-toxic single thyroid nodule	0.797	0.203	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.772	0.228	0.000
E06.3 Autoimmune thyroiditis	0.727	0.273	0.000
E05.9 Thyrotoxicosis, unspecified	0.723	0.277	0.000
E07.8 Other specified disorders of thyroid	0.721	0.278	0.000
E04.8 Other specified non-toxic goitre	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.685	0.315	0.000
E00 Congenital iodine-deficiency syndrome	0.685	0.315	0.000
E06.9 Thyroiditis, unspecified	0.684	0.316	0.000
E05.5 Thyroid crisis or storm	0.659	0.341	0.000
E05.4 Thyrotoxicosis factitia	0.659	0.341	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.659	0.341	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.659	0.341	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.649	0.351	0.000
E07.1 Dyshormogenetic goitre	0.642	0.358	0.000
E07.0 Hypersecretion of calcitonin	0.642	0.358	0.000
E06.1 Subacute thyroiditis	0.635	0.365	0.000
E05.8 Other thyrotoxicosis	0.624	0.376	0.000
E06.5 Other chronic thyroiditis	0.609	0.391	0.000
E06.4 Drug-induced thyroiditis	0.609	0.391	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.609	0.391	0.000
E06.0 Acute thyroiditis	0.609	0.391	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.491	0.509	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.491	0.509	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.491	0.509	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.491	0.509	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.491	0.509	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.491	0.509	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.491	0.509	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.491	0.509	0.000
E03 Other hypothyroidism	0.243	0.757	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.180	0.820	0.000
E03.5 Myxoedema coma	0.174	0.825	0.000
E03.4 Atrophy of thyroid (acquired)	0.174	0.825	0.000
E03.3 Postinfectious hypothyroidism	0.174	0.825	0.000
E03.1 Congenital hypothyroidism without goitre	0.174	0.825	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.174	0.825	0.000
E89.0 Postprocedural hypothyroidism	0.158	0.842	0.000
Y83.3 Surgical operation with formation of external stoma	0.133	0.867	0.000
E03.8 Other specified hypothyroidism	0.085	0.914	0.001
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.084	0.916	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.924	0.076
L89 Decubitus ulcer	0.000	0.928	0.072
E89.8 Other postprocedural endocrine and metabolic disorders	0.069	0.931	0.000
L89.1 Stage II decubitus ulcer	0.000	0.935	0.065
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.936	0.064
L89.2 Stage III decubitus ulcer	0.000	0.936	0.064
E89.4 Postprocedural ovarian failure	0.061	0.939	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.060	0.940	0.000
E89.5 Postprocedural testicular hypofunction	0.060	0.940	0.000
E89.1 Postprocedural hypoinsulinaemia	0.060	0.940	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.057	0.943	0.000
E89.2 Postprocedural hypoparathyroidism	0.056	0.943	0.000
L89.3 Stage IV decubitus ulcer	0.000	0.946	0.054
E89.3 Postprocedural hypopituitarism	0.053	0.946	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.046	0.954	0.000
N35.9 Urethral stricture, unspecified	0.000	0.956	0.044
E50-E64 Other nutritional deficiencies	0.038	0.962	0.000
E55 Vitamin D deficiency	0.035	0.965	0.000
E55.9 Vitamin D deficiency, unspecified	0.033	0.967	0.000
E70-E90 Metabolic disorders	0.032	0.968	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.970	0.030
E40-E46 Malnutrition	0.030	0.970	0.000
E56 Other vitamin deficiencies	0.029	0.971	0.000
E20-E35 Disorders of other endocrine glands	0.029	0.971	0.000
E58 Dietary calcium deficiency	0.028	0.971	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.028	0.972	0.000
E63 Other nutritional deficiencies	0.028	0.972	0.000
E51 Thiamine deficiency	0.028	0.972	0.000
E50 Vitamin A deficiency	0.028	0.972	0.000
E60 Dietary zinc deficiency	0.028	0.972	0.000
E59 Dietary selenium deficiency	0.028	0.972	0.000
E54 Ascorbic acid deficiency	0.028	0.972	0.000
E52 Niacin deficiency [pellagra]	0.028	0.972	0.000
T43.2 Other and unspecified antidepressants	0.000	0.973	0.027
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.973	0.027
N35 Urethral stricture	0.000	0.973	0.026
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.026	0.974	0.000
E55.0 Rickets, active	0.025	0.974	0.000
E61 Deficiency of other nutrient elements	0.025	0.975	0.000
E34 Other endocrine disorders	0.024	0.976	0.000
E22 Hyperfunction of pituitary gland	0.024	0.976	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.023	0.977	0.000
N35.8 Other urethral stricture	0.000	0.977	0.023
E84 Cystic fibrosis	0.023	0.977	0.000
E77 Disorders of glycoprotein metabolism	0.023	0.977	0.000
E76 Disorders of glycosaminoglycan metabolism	0.023	0.977	0.000
E72 Other disorders of amino-acid metabolism	0.023	0.977	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.023	0.977	0.000
E70 Disorders of aromatic amino-acid metabolism	0.023	0.977	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.023	0.977	0.000
E56.1 Deficiency of vitamin K	0.022	0.978	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.978	0.022
E28 Ovarian dysfunction	0.022	0.978	0.000
E27 Other disorders of adrenal gland	0.022	0.978	0.000
E85 Amyloidosis	0.022	0.978	0.000
E22.1 Hyperprolactinaemia	0.022	0.978	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.022	0.978	0.000
E45 Retarded development following protein-energy malnutrition	0.022	0.978	0.000
E43 Unspecified severe protein-energy malnutrition	0.022	0.978	0.000
E42 Marasmic kwashiorkor	0.022	0.978	0.000
E41 Nutritional marasmus	0.022	0.978	0.000
E40 Kwashiorkor	0.022	0.978	0.000
E74 Other disorders of carbohydrate metabolism	0.022	0.978	0.000
E73 Lactose intolerance	0.022	0.978	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.978	0.021
E53 Deficiency of other B group vitamins	0.021	0.978	0.000
E34.0 Carcinoid syndrome	0.021	0.979	0.000
E56.9 Vitamin deficiency, unspecified	0.021	0.979	0.000
E56.8 Deficiency of other vitamins	0.021	0.979	0.000
E56.0 Deficiency of vitamin E	0.021	0.979	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.021	0.979	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.021	0.979	0.000
E32 Diseases of thymus	0.021	0.979	0.000
E31 Polyglandular dysfunction	0.021	0.979	0.000
E30 Disorders of puberty, not elsewhere classified	0.021	0.979	0.000
E79 Disorders of purine and pyrimidine metabolism	0.021	0.979	0.000
E25 Adrenogenital disorders	0.021	0.979	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.021	0.979	0.000
E34.8 Other specified endocrine disorders	0.020	0.980	0.000
E50.9 Vitamin A deficiency, unspecified	0.020	0.980	0.000
E50.8 Other manifestations of vitamin A deficiency	0.020	0.980	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.020	0.980	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.020	0.980	0.000
E50.5 Vitamin A deficiency with night blindness	0.020	0.980	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.020	0.980	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.020	0.980	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.020	0.980	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.020	0.980	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.020	0.980	0.000
E51.9 Thiamine deficiency, unspecified	0.020	0.980	0.000
E51.8 Other manifestations of thiamine deficiency	0.020	0.980	0.000
E51.2 Wernicke's encephalopathy	0.020	0.980	0.000
E51.1 Beriberi	0.020	0.980	0.000
E63.9 Nutritional deficiency, unspecified	0.020	0.980	0.000
E63.8 Other specified nutritional deficiencies	0.020	0.980	0.000
E63.1 Imbalance of constituents of food intake	0.020	0.980	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.020	0.980	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.020	0.980	0.000
E64.8 Sequelae of other nutritional deficiencies	0.020	0.980	0.000
E64.3 Sequelae of rickets	0.020	0.980	0.000
E64.2 Sequelae of vitamin C deficiency	0.020	0.980	0.000
E64.1 Sequelae of vitamin A deficiency	0.020	0.980	0.000
E64.0 Sequelae of protein-energy malnutrition	0.020	0.980	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.980	0.019
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.980	0.019
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.980	0.019
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.981	0.019
N35.0 Posttraumatic urethral stricture	0.000	0.981	0.019
E27.4 Other and unspecified adrenocortical insufficiency	0.019	0.981	0.000
E26 Hyperaldosteronism	0.019	0.981	0.000
E15 Nondiabetic hypoglycaemic coma	0.019	0.981	0.000
E46 Unspecified protein-energy malnutrition	0.019	0.981	0.000
E85.8 Other amyloidosis	0.018	0.981	0.000
E20 Hypoparathyroidism	0.018	0.981	0.000
E61.9 Deficiency of nutrient element, unspecified	0.018	0.981	0.000
E61.8 Deficiency of other specified nutrient elements	0.018	0.981	0.000
E61.7 Deficiency of multiple nutrient elements	0.018	0.981	0.000
E61.6 Vanadium deficiency	0.018	0.981	0.000
E61.5 Molybdenum deficiency	0.018	0.981	0.000
E61.4 Chromium deficiency	0.018	0.981	0.000
E61.3 Manganese deficiency	0.018	0.981	0.000
E61.0 Copper deficiency	0.018	0.981	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.981	0.018
E85.4 Organ-limited amyloidosis	0.018	0.982	0.000
E61.2 Magnesium deficiency	0.018	0.982	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.018	0.982	0.000
E80.2 Other porphyria	0.018	0.982	0.000
E23 Hypofunction and other disorders of pituitary gland	0.018	0.982	0.000
E34.5 Androgen resistance syndrome	0.018	0.982	0.000
E34.4 Constitutional tall stature	0.018	0.982	0.000
E34.3 Short stature, not elsewhere classified	0.018	0.982	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.018	0.982	0.000
E34.1 Other hypersecretion of intestinal hormones	0.018	0.982	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.018	0.982	0.000
E75.5 Other lipid storage disorders	0.017	0.983	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.017	0.983	0.000
E22.8 Other hyperfunction of pituitary gland	0.017	0.983	0.000
E28.2 Polycystic ovarian syndrome	0.017	0.983	0.000
E75.6 Lipid storage disorder, unspecified	0.017	0.983	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.017	0.983	0.000
E75.3 Sphingolipidosis, unspecified	0.017	0.983	0.000
E75.2 Other sphingolipidosis	0.017	0.983	0.000
E75.1 Other gangliosidosis	0.017	0.983	0.000
E75.0 GM2 gangliosidosis	0.017	0.983	0.000
E61.1 Iron deficiency	0.017	0.983	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.017	0.983	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.017	0.983	0.000
E70.3 Albinism	0.017	0.983	0.000
E70.2 Disorders of tyrosine metabolism	0.017	0.983	0.000
E70.1 Other hyperphenylalaninaemias	0.017	0.983	0.000
E70.0 Classical phenylketonuria	0.017	0.983	0.000
E71.3 Disorders of fatty-acid metabolism	0.017	0.983	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.017	0.983	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.017	0.983	0.000
E71.0 Maple-syrup-urine disease	0.017	0.983	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.017	0.983	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.017	0.983	0.000
E72.5 Disorders of glycine metabolism	0.017	0.983	0.000
E72.4 Disorders of ornithine metabolism	0.017	0.983	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.017	0.983	0.000
E72.2 Disorders of urea cycle metabolism	0.017	0.983	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.017	0.983	0.000
E72.0 Disorders of amino-acid transport	0.017	0.983	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.017	0.983	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.017	0.983	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.017	0.983	0.000
E76.2 Other mucopolysaccharidoses	0.017	0.983	0.000
E76.1 Mucopolysaccharidosis, type II	0.017	0.983	0.000
E76.0 Mucopolysaccharidosis, type I	0.017	0.983	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.017	0.983	0.000
E77.8 Other disorders of glycoprotein metabolism	0.017	0.983	0.000
E77.1 Defects in glycoprotein degradation	0.017	0.983	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.017	0.983	0.000
E84.9 Cystic fibrosis, unspecified	0.017	0.983	0.000
E84.8 Cystic fibrosis with other manifestations	0.017	0.983	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.017	0.983	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.017	0.983	0.000
E28.3 Primary ovarian failure	0.017	0.983	0.000
E65-E68 Obesity and other hyperalimentation	0.016	0.983	0.000
E21.0 Primary hyperparathyroidism	0.016	0.984	0.000
E28.9 Ovarian dysfunction, unspecified	0.016	0.984	0.000
E28.8 Other ovarian dysfunction	0.016	0.984	0.000
E28.1 Androgen excess	0.016	0.984	0.000
E28.0 Oestrogen excess	0.016	0.984	0.000
E27.5 Adrenomedullary hyperfunction	0.016	0.984	0.000
E27.0 Other adrenocortical overactivity	0.016	0.984	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.016	0.984	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.016	0.984	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.016	0.984	0.000
E29 Testicular dysfunction	0.016	0.984	0.000
E53.9 Vitamin B deficiency, unspecified	0.016	0.984	0.000
E44.1 Mild protein-energy malnutrition	0.016	0.984	0.000
E44.0 Moderate protein-energy malnutrition	0.016	0.984	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.016	0.984	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.016	0.984	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.016	0.984	0.000
E74.2 Disorders of galactose metabolism	0.016	0.984	0.000
E74.1 Disorders of fructose metabolism	0.016	0.984	0.000
E74.0 Glycogen storage disease	0.016	0.984	0.000
E73.8 Other lactose intolerance	0.016	0.984	0.000
E73.1 Secondary lactase deficiency	0.016	0.984	0.000
E73.0 Congenital lactase deficiency	0.016	0.984	0.000
E27.8 Other specified disorders of adrenal gland	0.016	0.984	0.000
E53.1 Pyridoxine deficiency	0.016	0.984	0.000
E53.0 Riboflavin deficiency	0.016	0.984	0.000
E27.2 Addisonian crisis	0.015	0.985	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.015	0.985	0.000
E88 Other metabolic disorders	0.015	0.985	0.000
E21.4 Other specified disorders of parathyroid gland	0.015	0.985	0.000
E21.2 Other hyperparathyroidism	0.015	0.985	0.000
E30.9 Disorder of puberty, unspecified	0.015	0.985	0.000
E30.8 Other disorders of puberty	0.015	0.985	0.000
E30.1 Precocious puberty	0.015	0.985	0.000
E30.0 Delayed puberty	0.015	0.985	0.000
E31.9 Polyglandular dysfunction, unspecified	0.015	0.985	0.000
E31.8 Other polyglandular dysfunction	0.015	0.985	0.000
E31.1 Polyglandular hyperfunction	0.015	0.985	0.000
E31.0 Autoimmune polyglandular failure	0.015	0.985	0.000
E32.9 Disease of thymus, unspecified	0.015	0.985	0.000
E32.8 Other diseases of thymus	0.015	0.985	0.000
E32.1 Abscess of thymus	0.015	0.985	0.000
E32.0 Persistent hyperplasia of thymus	0.015	0.985	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.015	0.985	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.015	0.985	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.015	0.985	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.015	0.985	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.015	0.985	0.000
E79.1 Lesch-Nyhan syndrome	0.015	0.985	0.000
E24 Cushing's syndrome	0.015	0.985	0.000
E27.9 Disorder of adrenal gland, unspecified	0.015	0.985	0.000
E22.0 Acromegaly and pituitary gigantism	0.015	0.985	0.000
E25.9 Adrenogenital disorder, unspecified	0.015	0.985	0.000
E25.8 Other adrenogenital disorders	0.015	0.985	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.015	0.985	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.015	0.985	0.000
E80.5 Crigler-Najjar syndrome	0.015	0.985	0.000
E80.3 Defects of catalase and peroxydase	0.015	0.985	0.000
E80.1 Porphyria cutanea tarda	0.015	0.985	0.000
E80.0 Hereditary erythropoietic porphyria	0.015	0.985	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.015	0.985	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.015	0.985	0.000
E73.9 Lactose intolerance, unspecified	0.014	0.986	0.000
E27.1 Primary adrenocortical insufficiency	0.014	0.986	0.000
E85.3 Secondary systemic amyloidosis	0.014	0.986	0.000
E26.9 Hyperaldosteronism, unspecified	0.014	0.986	0.000
E26.8 Other hyperaldosteronism	0.014	0.986	0.000
E26.1 Secondary hyperaldosteronism	0.014	0.986	0.000
E80.6 Other disorders of bilirubin metabolism	0.014	0.986	0.000
E20.8 Other hypoparathyroidism	0.013	0.986	0.000
E20.1 Pseudohypoparathyroidism	0.013	0.986	0.000
E20.0 Idiopathic hypoparathyroidism	0.013	0.986	0.000
E23.7 Disorder of pituitary gland, unspecified	0.013	0.987	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.013	0.987	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.013	0.987	0.000
E23.1 Drug-induced hypopituitarism	0.013	0.987	0.000
E83 Disorders of mineral metabolism	0.013	0.987	0.000
E23.0 Hypopituitarism	0.013	0.987	0.000
E34.9 Endocrine disorder, unspecified	0.012	0.988	0.000
E67 Other hyperalimentation	0.012	0.988	0.000
E68 Sequelae of hyperalimentation	0.012	0.988	0.000
E23.6 Other disorders of pituitary gland	0.012	0.988	0.000
E26.0 Primary hyperaldosteronism	0.012	0.988	0.000
E29.9 Testicular dysfunction, unspecified	0.012	0.988	0.000
E29.8 Other testicular dysfunction	0.012	0.988	0.000
E29.0 Testicular hyperfunction	0.012	0.988	0.000
E88.8 Other specified metabolic disorders	0.011	0.988	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.989	0.011
E88.2 Lipomatosis, not elsewhere classified	0.011	0.989	0.000
E88.9 Metabolic disorder, unspecified	0.011	0.989	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.011	0.989	0.000
E20.9 Hypoparathyroidism, unspecified	0.011	0.989	0.000
E24.8 Other Cushing's syndrome	0.011	0.989	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.011	0.989	0.000
E24.3 Ectopic ACTH syndrome	0.011	0.989	0.000
E24.1 Nelson's syndrome	0.011	0.989	0.000
E83.4 Disorders of magnesium metabolism	0.011	0.989	0.000
E16 Other disorders of pancreatic internal secretion	0.011	0.989	0.000
E85.9 Amyloidosis, unspecified	0.011	0.989	0.000
E83.3 Disorders of phosphorus metabolism	0.011	0.989	0.000
E24.2 Drug-induced Cushing's syndrome	0.010	0.989	0.000
E23.2 Diabetes insipidus	0.010	0.990	0.000
E88.3 Tumour lysis syndrome	0.010	0.990	0.000
E24.0 Pituitary-dependent Cushing's disease	0.010	0.990	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.009	0.990	0.000
E83.8 Other disorders of mineral metabolism	0.009	0.990	0.000
E83.2 Disorders of zinc metabolism	0.009	0.990	0.000
E83.0 Disorders of copper metabolism	0.009	0.990	0.000
M25.51 Pain in joint (Shoulder region)	0.000	0.991	0.009
E67.8 Other specified hyperalimentation	0.009	0.991	0.000
E67.3 Hypervitaminosis D	0.009	0.991	0.000
E67.2 Megavitamin-B6 syndrome	0.009	0.991	0.000
E67.1 Hypercarotenaemia	0.009	0.991	0.000
E67.0 Hypervitaminosis A	0.009	0.991	0.000
E65 Localised adiposity	0.008	0.991	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.991	0.009
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.992	0.008
E24.9 Cushing's syndrome, unspecified	0.008	0.992	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.992	0.008
E16.9 Disorder of pancreatic internal secretion, unspecified	0.008	0.992	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.008	0.992	0.000
E16.4 Abnormal secretion of gastrin	0.008	0.992	0.000
E16.3 Increased secretion of glucagon	0.008	0.992	0.000
E53.8 Deficiency of other specified B group vitamins	0.008	0.992	0.000
E21.3 Hyperparathyroidism, unspecified	0.008	0.992	0.000
E80.4 Gilbert's syndrome	0.008	0.992	0.000
E16.1 Other hypoglycaemia	0.008	0.992	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.993	0.007
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.993	0.007
E29.1 Testicular hypofunction	0.007	0.993	0.000
I31.3 Pericardial effusion (noninflammatory)	0.000	0.993	0.007
E16.0 Drug-induced hypoglycaemia without coma	0.007	0.993	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.007	0.993	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.993	0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.993	0.007
T36 Poisoning by systemic antibiotics	0.000	0.994	0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.994	0.006
S42.20 Fracture of upper end of humerus (closed)	0.006	0.994	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.994	0.006
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.994	0.006
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.994	0.006
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.994	0.006
T46.7 Peripheral vasodilators	0.000	0.994	0.006
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.994	0.006
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.994	0.006
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.006	0.994	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.994	0.006
T46.1 Calcium-channel blockers	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.994	0.006
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.994	0.006
T38.1 Thyroid hormones and substitutes	0.000	0.994	0.006
T38.9 Other and unspecified hormone antagonists	0.000	0.994	0.005
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.994	0.005
T38.7 Androgens and anabolic congeners	0.000	0.994	0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.994	0.005
T38.5 Other oestrogens and progestogens	0.000	0.994	0.005
T38.4 Oral contraceptives	0.000	0.994	0.005
T38.2 Antithyroid drugs	0.000	0.994	0.005
T38.0 Glucocorticoids and synthetic analogues	0.000	0.994	0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.994	0.005
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.995	0.005
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.995	0.005
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.995	0.005
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.005
G30.9 Alzheimer's disease, unspecified	0.005	0.995	0.000
S42.2 Fracture of upper end of humerus	0.005	0.995	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.995	0.005
O02.1 Missed abortion	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.995	0.005
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
T47.7 Emetics	0.000	0.995	0.005
T47.6 Antidiarrhoeal drugs	0.000	0.995	0.005
T47.5 Digestants	0.000	0.995	0.005
T47.4 Other laxatives	0.000	0.995	0.005
T47.3 Saline and osmotic laxatives	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
T47.0 Histamine H(2)-receptor antagonists	0.000	0.995	0.005
T36.0 Penicillins	0.000	0.995	0.005
T45.2 Vitamins, not elsewhere classified	0.000	0.995	0.005
T36.9 Systemic antibiotic, unspecified	0.000	0.995	0.005
T36.8 Other systemic antibiotics	0.000	0.995	0.005
T36.7 Antifungal antibiotics, systemically used	0.000	0.995	0.005
T36.6 Rifamycins	0.000	0.995	0.005
T36.5 Aminoglycosides	0.000	0.995	0.005
T36.4 Tetracyclines	0.000	0.995	0.005
T36.3 Macrolides	0.000	0.995	0.005
T36.2 Chloramphenicol group	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.005
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.995	0.005
S42.00 Fracture of clavicle (closed)	0.005	0.995	0.000
F00 Dementia in Alzheimer's disease	0.005	0.995	0.000
T45.5 Anticoagulants	0.000	0.995	0.005
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.995	0.005
T41.5 Therapeutic gases	0.000	0.995	0.005
T41.4 Anaesthetic, unspecified	0.000	0.995	0.005
T41.3 Local anaesthetics	0.000	0.995	0.005
T41.2 Other and unspecified general anaesthetics	0.000	0.995	0.005
T41.1 Intravenous anaesthetics	0.000	0.995	0.005
T41.0 Inhaled anaesthetics	0.000	0.995	0.005
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.995	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.995	0.005
T45.8 Other primarily systemic and haematological agents	0.000	0.995	0.005
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.995	0.005
T45.6 Fibrinolysis-affecting drugs	0.000	0.995	0.005
T45.4 Iron and its compounds	0.000	0.995	0.005
T45.3 Enzymes, not elsewhere classified	0.000	0.995	0.005
T49.9 Topical agent, unspecified	0.000	0.995	0.005
T49.8 Other topical agents	0.000	0.995	0.005
T49.7 Dental drugs, topically applied	0.000	0.995	0.005
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.995	0.005
T49.5 Ophthalmological drugs and preparations	0.000	0.995	0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.995	0.005
T49.3 Emollients, demulcents and protectants	0.000	0.995	0.005
T49.2 Local astringents and local detergents	0.000	0.995	0.005
T49.1 Antipruritics	0.000	0.995	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.995	0.005
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.004	0.995	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.005	0.995	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.995	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.995	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.995	0.004
T44.0 Anticholinesterase agents	0.000	0.995	0.004
T42.4 Benzodiazepines	0.000	0.995	0.005
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.995	0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.995	0.005
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.004	0.995	0.000
S42.0 Fracture of clavicle	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.996	0.004
G31.0 Circumscribed brain atrophy	0.004	0.996	0.000
I31 Other diseases of pericardium	0.000	0.996	0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.996	0.004
T48.4 Expectorants	0.000	0.996	0.004
T48.3 Antitussives	0.000	0.996	0.004
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.996	0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.996	0.004
T48.0 Oxytocic drugs	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
I31.9 Disease of pericardium, unspecified	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
K13.7 Other and unspecified lesions of oral mucosa	0.004	0.996	0.000
G30 Alzheimer's disease	0.004	0.996	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.004
T37.5 Antiviral drugs	0.000	0.996	0.004
T37.4 Anthelminthics	0.000	0.996	0.004
T37.3 Other antiprotozoal drugs	0.000	0.996	0.004
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.004
T37.1 Antimycobacterial drugs	0.000	0.996	0.004
T37.0 Sulphonamides	0.000	0.996	0.004
S42 Fracture of shoulder and upper arm	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.996	0.004
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.996	0.004
T42.3 Barbiturates	0.000	0.996	0.004
T42.2 Succinimides and oxazolidinediones	0.000	0.996	0.004
E66 Obesity	0.004	0.996	0.000
F02 Dementia in other diseases classified elsewhere	0.004	0.996	0.000
G31.8 Other specified degenerative diseases of nervous system	0.004	0.996	0.000
E16.2 Hypoglycaemia, unspecified	0.004	0.996	0.000
S42.21 Fracture of upper end of humerus (open)	0.004	0.996	0.000
F02.0 Dementia in Pick's disease	0.004	0.996	0.000
K60.3 Anal fistula	0.000	0.996	0.004
C77.2 Intra-abdominal lymph nodes	0.000	0.996	0.004
M19.94 Arthrosis, unspecified (Hand)	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.004
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.004
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.004

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations